News 5 Cleveland (Your Health Matters)
6/12 4:44A
Scripps News Group
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness. The drug, Enflonsia, is a long-acting monoclonal antibody...